ステージIIB/IICメラノーマにおける補助免疫療法:現在の証拠と将来の方向
Ivana Prkačin1,2, Ana Brkić1, Nives Pondeljak3
1Department of Dermatology and Venereology, Sestre Milosrdnice University Hospital Center, 10000 Zagreb, Croatia.
Biomedicines
|August 28, 2025
まとめ
PD- 1 阻害剤による補助免疫療法は,ステージIIB/ IICのメラノーマ患者の再発のない生存率を改善します. しかし,全生存効果と毒性は,最適な患者の選択のためにさらなる調査を必要とします.
科学分野:
- 腫瘍学
- 免疫学
- 皮膚科
背景:
- 切除されたステージIIBおよびIICのメラノーマ患者は,手術後の再発および転移のリスクが高い.
- 免疫チェックポイント阻害剤 (ICI) は,早期メラノーマにおける補助療法として評価されています.
研究 の 目的:
- ステージIIB/IICのメラノーマに対する補助免疫療法に関する現在の証拠をレビューする.
- メラノーマ治療における新たな戦略,課題,将来の方向性を探求する.
主な方法:
- 臨床試験,観察研究,バイオマーカー研究に関する包括的な文献レビュー.
- PD-1 阻害剤試験 (KEYNOTE-716, CheckMate 76K),新しい治療法,耐性メカニズム,毒性,およびバイオマーカーに焦点を当てた分析.
主要な成果:
- ペムブロリズマブとニボルマブは,プラセボと比較して,リキュアンスフリー生存率 (RFS) と遠隔転移フリー生存率 (DMFS) を有意に改善しました.
- 免疫関連の有害事象は,内分泌病変を含む.
- ctDNAモニタリングと遺伝子発現プロファイリングのような個別化された調査アプローチは,患者の選択を助けることができます.
結論:
- 補助的なPD- 1阻害は,高リスクのステージIIのメラノーマに対して,有意なRFS効果をもたらします.
- 全体の生存効果と毒性の懸念が不確実であるため,最適な患者の選択は困難です.
- 将来の試験は,治療決定を精密にし,過剰治療を減らすために,バイオマーカー主導の戦略を統合する必要があります.
関連する概念動画
01:27Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
01:30Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:30Skin Cancer
4.5K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.5K